Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

ACCC would like to recognize the members of the Social Drivers of Health advisory committee & MBC steering committee.
June 28, 2023
The unwinding of Medicaid has begun and affects one of the most vulnerable U.S. regions’ access to cancer-related services—from screening to treatment. In this webinar, the Appalachian Community Cancer Alliance provides an opportunity to gain insight on the scale of impact and how to help ensure continued access to cancer screening and treatment services for this patient population.
Oncology Icons is an award program created by Targeted Oncology™ that highlights the exceptional work of community oncologists. A quarterly Oncology Icons article is published on the Targeted Oncology™ website and in Targeted Therapies in Oncology™. In addition to being featured in a quarterly article, honorees are offered several opportunities to share their unique expertise with the oncology …
Developing a Health Literacy and Clear Communications e-Course AGENDA 6:45 am Registration Open, Networking Breakfast / Resource Center 7:30 am Welcome & Introductions Susannah P. Friemel, MD President, Iowa Oncology Society 7:45 am Melanoma/HCC Asad Javed, MBBS 8:15 am Breast Cancer Vikas Praveen, MD 8:45 am Multiply Myelomas Christopher Strouse, MD 9:15 am Networking …
Advanced Practice Providers (APPs), such as nurse practitioners and physician assistants, play a fundamental role within medical oncology departments and the care of patients with cancer.
Prostate Cancer: Therapeutic Sequencing for Metastatic Castration-Resistant Prostate Cancer MODERATOR Dr. Song Zhao Swedish Cancer Institute targetedonc.com/events Register Today We will discuss 2 cases of metastatic castration- resistant prostate cancer, one metastatic at diagnosis and one recurrent. Join Targeted Oncology™ for a collaborative, small- group meeting designed …
June 24, 2023
There are numerous challenges for clinicians who manage patients with hepatocellular cancer (HCC). This includes diagnosing and staging patients in a timely manner while staying abreast with the latest clinical advances in the field.
Make Your Case Show your supervisor the value of attending! August 4-5th, 2023 | Wild Dunes Resort Isle of Palms, SC 2023 SCOSAnnual Conference Dear I would like to attend the South Carolina Oncology Society (SCOS) 2023 Annual Conference taking place August 4-5, 2023. This conference offers a valuable opportunity to engage with peers, enhance our knowledge in cancer care, and …
Exhibit Schedule Tentative and subject to change Wednesday – October 4, 2023 11:00 am – 4:00 pm Exhibitor Move-in 5:30 pm – 7:00 pm Exhibit Hall Open Opening Welcome Reception & Poster Presentations Thursday – October 5, 2023 7:00 am – 4:00 pm Exhibit Hall Open Unopposed Hours: 7:00 am – 8:00 am Breakfast with Exhibitors 10:00 am – 10:30 am …
Mary B. Battaglia has been practicing clinical hypnosis for 10 years, working with clients to address issues like anxiety and stress and supported people with different medical issues, including brain, breast, lung, prostate, and skin cancers.
June 23, 2023
In this workshop, provided by the France Foundation, interactive formats will allow the multidisciplinary care team to continuously assess knowledge gaps.
Oncology Practice Summit Sheraton Indianapolis Hotel at Keystone Crossing | August 11, 2023 Agenda 7:15 AM Registration Open, Networking Breakfast in Resource Center 8:00 AM Welcome & Introduction Mary Miller, MSN, RN-BC, OCN, CNE President, Indiana Oncology Society 8:15 AM Financial Advocacy Aimee Hoch, LSW, OSW-C Financial Director, Grandview Health …
While there are many factors why patients with acute myeloid leukemia are ineligible for allogeneic stem cell transplant, such as age, financial hurdles, or other comorbidities, these factors are often compounded by social determinants of health, which can act as a significant barrier to consolidation therapy and long-term remission for these patients. In this episode, CANCER BUZZ speaks with Keri …
ACCC set out to identify and understand specific regional challenges to appropriate and equitable care for patients with chronic lymphocytic leukemia, the most common form of leukemia in adults.
For National Pride Month this year, the Association of Community Cancer Centers (ACCC) is highlighting the transgender community and what it means for cancer programs and practices nationwide to provide trans-inclusive care.
New Molecular Entities • EpkinlyTM (epcoritamab-bysp) – The “broad oncology collaboration” announced by Abbvie and Genmab 3 years ago yielded its first “fruits’ this month with the accelerated approval of EpkinklyTM, a novel bispecific antibody, that binds a protein (CD3) found on T-cells to CD20, a protein that is overexpressed on the surface of lymphoma cells. The approval is for use for …
New Molecular Entities • EpkinlyTM (epcoritamab-bysp) – The “broad oncology collaboration” announced by Abbvie and Genmab 3 years ago yielded its first “fruits’ this month with the accelerated approval of EpkinklyTM, a novel bispecific antibody, that binds a protein (CD3) found on T-cells to CD20, a protein that is overexpressed on the surface of lymphoma cells. The approval is for use for …
New Molecular Entities • EpkinlyTM (epcoritamab-bysp) – The “broad oncology collaboration” announced by Abbvie and Genmab 3 years ago yielded its first “fruits’ this month with the accelerated approval of EpkinklyTM, a novel bispecific antibody, that binds a protein (CD3) found on T-cells to CD20, a protein that is overexpressed on the surface of lymphoma cells. The approval is for use for …
New Molecular Entities • EpkinlyTM (epcoritamab-bysp) – The “broad oncology collaboration” announced by Abbvie and Genmab 3 years ago yielded its first “fruits’ this month with the accelerated approval of EpkinklyTM, a novel bispecific antibody, that binds a protein (CD3) found on T-cells to CD20, a protein that is overexpressed on the surface of lymphoma cells. The approval is for use for …
Corporate Membership Terms and Conditions 2024 1 OVERVIEW: Washington State Medical Oncology Society (WSMOS) is a member of The Oncology State Societies at ACCC, a network of 23 State Chapters that are managed by—and collaborate with—the Association of Community Cancer Centers (ACCC) and are members of the American Society of Clinical Oncology State/Regional Affiliate Program. …